ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 891,68
-0,19%
Dow Jones
44 803,18
0,55%
DAX
21 585,93
0,35%
Brent Oil
74,52
-1,87%
Bitcoin
97 200,83
-0,67%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV

  6. LSL Pharma Group Inc (LSL) Cours

LSL Pharma Group Inc

LSL Pharma Group Inc (LSL)

Lsl Property Services Plc
0,36
0,00
( 0,00% )
Mis à jour : 17:39:16
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,36
Prix Achat
0,355
Prix Vente
0,365
Volume échangé
43 700
0,36 Fourchette du Jour 0,365
0,00 Plage de 52 semaines 0,00
Cap du marché
29,677M
Clôture Veille
0,36
Ouverture
0,36
Dernière Transaction
200
@
0.36
Dernière heure de transaction
17:39:13
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
82 435 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,50
Bénéfice par action (BPA)
-0,1
Chiffre d'affairess
10,03M
Bénéfice net
-8,47M

À propos de LSL Pharma Group Inc

Secteur
Pharmaceutical Preparations
Industrie
Blank Checks
Site Web
www.groupelslpharma.com
Siège social
Quebec City, Quebec, Can
Fondé
2011
LSL Pharma Group Inc est coté dans le secteur Pharmaceutical Preparations de la TSX Venture Exchange avec le ticker LSL. Le dernier cours de clôture d'LSL Pharma était de $0,36. Au cours de la dernière année, les actions de LSL Pharma ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

LSL Pharma compte actuellement 82 435 000 actions en circulation. La capitalisation boursière d'LSL Pharma est de $29,68 million. LSL Pharma a un ratio cours/bénéfice (ratio PE) de -3.50.

LSL Dernières nouvelles

Plus de nouvelles

LSL Pharma Group Announces Closing of Second and Final Tranche of Private Placement and Closing of Units for Debt

BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to...

15 Juillet 2024
GlobeNewswire Inc.

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased...

28 Juin 2024
GlobeNewswire Inc.

LSL Pharma Group Secures $1.5 Million as the First Closing of Its Non-Brokered Private Placement

BOUCHERVILLE, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced...

27 Juin 2024
GlobeNewswire Inc.

LSL Pharma Group Completes the Acquisition of Virage Santé

BOUCHERVILLE, Québec, June 18, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to...

18 Juin 2024
GlobeNewswire Inc.

LSL Pharma Group Announces Engagement of Red Cloud Securities

BOUCHERVILLE, Quebec, June 11, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, announces that...

11 Juin 2024
GlobeNewswire Inc.

LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million

Up to $3.0 M in cash proceedsUp to $1.5 M in debts conversion BOUCHERVILLE, Quebec, June 05, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a...

05 Juin 2024
GlobeNewswire Inc.

LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024

Record Revenues of $4.2 million in Q1-24 up 106% over Q1-23Record Adjusted Gross margins for Q1-24 of $1.6 million up 141% over Q1-23Operating profits of $0.2 million for Q1-24 compared to a loss...

30 Mai 2024
GlobeNewswire Inc.

LSL Pharma Group Announces Listing of Convertible Redeemable Debentures on the TSXV

BOUCHERVILLE, Quebec, May 22, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to...

22 Mai 2024
GlobeNewswire Inc.

LSL Pharma Group Enters Into Binding Agreement to Acquire Quebec Competitor

Transaction expected to increase annual revenues by 15-20%Acquisition to boost overall profitabilityTransaction expected to close by end of Q2-24 BOUCHERVILLE, Québec, May 06, 2024 (GLOBE...

06 Mai 2024
GlobeNewswire Inc.

LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights

FY-2023 Revenues increased by 22% at $10.0 million compared to $8.2 million for FY-2022, a $1.8 million increase.Gross margins for FY-2023 up $3.8 million compared to FY-2022Net loss for FY-2023...

30 Avril 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

LSL - Frequently Asked Questions (FAQ)

What is the current LSL Pharma share price?
The current share price of LSL Pharma is $ 0,36
How many LSL Pharma shares are in issue?
LSL Pharma has 82 435 000 shares in issue
What is the market cap of LSL Pharma?
The market capitalisation of LSL Pharma is CAD 29,68M
What is the 1 year trading range for LSL Pharma share price?
LSL Pharma has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of LSL Pharma?
The price to earnings ratio of LSL Pharma is -3,5
What is the cash to sales ratio of LSL Pharma?
The cash to sales ratio of LSL Pharma is 2,96
What is the reporting currency for LSL Pharma?
LSL Pharma reports financial results in CAD
What is the latest annual turnover for LSL Pharma?
The latest annual turnover of LSL Pharma is CAD 10,03M
What is the latest annual profit for LSL Pharma?
The latest annual profit of LSL Pharma is CAD -8,47M
What is the registered address of LSL Pharma?
The registered address for LSL Pharma is 540, RUE D’AVAUGOUR, BOUCHERVILLE, QUEBEC CITY, QUEBEC, J4B 0G6
What is the LSL Pharma website address?
The website address for LSL Pharma is www.groupelslpharma.com
Which industry sector does LSL Pharma operate in?
LSL Pharma operates in the BLANK CHECKS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CVY.PCavalry Capital Corp
$ 0,07
(100,00%)
3k
ALMAlliance Mining Corp
$ 0,15
(76,47%)
30k
RTHRathdowney Resources Ltd
$ 0,025
(66,67%)
5,04k
GXY.PGalaxy Ventures Inc
$ 0,115
(53,33%)
1 000
HMANHuntsman Exploration Inc
$ 0,045
(50,00%)
30k
AGETAGEDB Technology Ltd
$ 0,025
(-86,11%)
19,5k
CANSWildpack Beverage Inc
$ 0,005
(-50,00%)
2k
CANDCandelaria Mining Corp
$ 0,005
(-50,00%)
332k
IDI.HIndico Resources Ltd
$ 0,35
(-50,00%)
1,5k
CLMConsolidated Lithium Metals Inc
$ 0,005
(-50,00%)
6k
OMIOrosur Mining Inc
$ 0,175
(-7,89%)
2,61M
DRYDryden Gold Corp
$ 0,14
(0,00%)
2,32M
SXLSlam Exploration Ltd
$ 0,025
(-16,67%)
2,18M
BVABravada Gold Corporation
$ 0,045
(12,50%)
2,08M
LUCALuca Mining Corp
$ 0,92
(1,10%)
2,07M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

TSXV
LSL
LSL Pharma
NYSE
KW
Kennedy Wilson
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces